問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2010-11-01 - 2012-06-30
Condition/Disease
Test Drug
Participate Sites10Sites
Terminated10Sites
2011-02-01 - 2013-12-31
Participate Sites6Sites
Terminated6Sites
2011-03-15 - 2017-12-31
Participate Sites5Sites
Terminated5Sites
2013-09-01 - 2019-03-08
Diffuse Large B-Cell Lymphoma(DLBCL)
Ibrutinib
Participate Sites4Sites
Terminated3Sites
Study ended1Sites
Division of Hematology & Oncology
2012-06-01 - 2013-12-31
Participate Sites3Sites
2012-11-01 - 2017-03-31
2007-12-10 - 2008-12-31
2008-03-31 - 2017-12-31
Participate Sites1Sites
Terminated1Sites
2008-05-13 - 2010-12-31
Participate Sites7Sites
Terminated7Sites
2007-11-20 - 2009-12-31
Terminated4Sites
全部
